Research in my group is focused on the use of (i) enhanced culture techniques, including culture of anaerobic bacteria and (ii) non culture methods based methods (next- generation sequencing, sensor technology) to improve the detection and treatment of lung infection in patients with respiratory diseases such as cystic fibrosis (CF), bronchiectasis and COPD.

We are also working extensively with academic and industrial partners to develop rapid point-of-care methods for detection of respiratory infection and to develop novel antibiotic treatments.